JP2024539609A5 - - Google Patents
Info
- Publication number
- JP2024539609A5 JP2024539609A5 JP2024521255A JP2024521255A JP2024539609A5 JP 2024539609 A5 JP2024539609 A5 JP 2024539609A5 JP 2024521255 A JP2024521255 A JP 2024521255A JP 2024521255 A JP2024521255 A JP 2024521255A JP 2024539609 A5 JP2024539609 A5 JP 2024539609A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- nucleic acid
- polypeptide
- vector
- item
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2114318.5 | 2021-10-06 | ||
| GBGB2114318.5A GB202114318D0 (en) | 2021-10-06 | 2021-10-06 | Coronavirus Vaccines |
| GBGB2214126.1A GB202214126D0 (en) | 2022-09-27 | 2022-09-27 | Coronavirus vaccines |
| GB2214126.1 | 2022-09-27 | ||
| PCT/GB2022/052537 WO2023057769A1 (en) | 2021-10-06 | 2022-10-06 | Coronavirus vaccines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024539609A JP2024539609A (ja) | 2024-10-29 |
| JP2024539609A5 true JP2024539609A5 (enExample) | 2025-10-15 |
Family
ID=83692901
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024521255A Pending JP2024539609A (ja) | 2021-10-06 | 2022-10-06 | コロナウイルスワクチン |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250312437A1 (enExample) |
| EP (1) | EP4412645A1 (enExample) |
| JP (1) | JP2024539609A (enExample) |
| CN (1) | CN119013040A (enExample) |
| AU (1) | AU2022358982A1 (enExample) |
| CA (1) | CA3234656A1 (enExample) |
| WO (1) | WO2023057769A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4687969A1 (en) * | 2023-04-05 | 2026-02-11 | DIOSynVax Ltd | Coronavirus vaccines inducing broad immunity against variants |
| WO2025083402A1 (en) * | 2023-10-16 | 2025-04-24 | Diosynvax Ltd | Coronavirus vaccines |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD3718565T2 (ro) | 2015-10-22 | 2022-09-30 | Modernatx Inc | Vaccinuri împotriva virusului respirator |
| EP3886897A1 (en) * | 2020-02-04 | 2021-10-06 | CureVac AG | Coronavirus vaccine |
| CA3167611A1 (en) * | 2020-02-13 | 2021-08-19 | Etienne Simon-Loriere | Nucleic acid vaccine against the sars-cov-2 coronavirus |
-
2022
- 2022-10-06 US US18/699,034 patent/US20250312437A1/en active Pending
- 2022-10-06 CN CN202280081276.XA patent/CN119013040A/zh active Pending
- 2022-10-06 EP EP22790007.3A patent/EP4412645A1/en active Pending
- 2022-10-06 CA CA3234656A patent/CA3234656A1/en active Pending
- 2022-10-06 AU AU2022358982A patent/AU2022358982A1/en active Pending
- 2022-10-06 JP JP2024521255A patent/JP2024539609A/ja active Pending
- 2022-10-06 WO PCT/GB2022/052537 patent/WO2023057769A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN115246874B (zh) | 一种重组新型冠状病毒s-rbd三聚体蛋白、其制备方法和应用 | |
| EP3294329B1 (en) | Novel baculovirus vectors and methods of use | |
| CA2209360A1 (en) | Recombinant monoclonal anti-idiotype antibody 3h1 sequences relating to human carcinoembryonic antigen | |
| CN110862435A (zh) | 非洲猪瘟ctl表位多肽及其应用 | |
| RU2003106809A (ru) | Гены гомологичных иммунодоминантных белков ehrlichia canis в 28-килодальтон и их применение | |
| US20110129498A1 (en) | Vaccine for the prevention and therapy of hcv infections | |
| JP2022513326A5 (enExample) | ||
| EA007154B1 (ru) | Слитый белок из числа регуляторных/вспомогательных белков вич | |
| CN115443288A (zh) | 一种免疫球蛋白降解酶IdeE的突变体 | |
| US7998484B2 (en) | Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines | |
| JP2019520058A5 (enExample) | ||
| JP2023522154A5 (enExample) | ||
| WO2013003579A1 (en) | Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of dengue virus infection | |
| JP2024537250A5 (enExample) | ||
| CN120475991A (zh) | 鼻病毒mRNA疫苗 | |
| US7247712B2 (en) | Complex of hepatitis B virus-specific antigenic peptides associated with heat shock proteins and the application thereof | |
| JPH0768267B2 (ja) | フラビウイルス抗原 | |
| KR20180038557A (ko) | 타겟 폴리펩티드를 제시하기 위한 폴리펩티드 캐리어 및 이의 용도 | |
| CA2660064A1 (en) | Promiscuous pap cd4 t cell epitopes | |
| WO2023160654A1 (zh) | 一种可诱导广谱中和活性重组多组分新冠病毒三聚体蛋白疫苗的制备及应用 | |
| BG105065A (en) | A vaccine-induced hepatitis b viral strain and uses thereof | |
| RU2001117860A (ru) | ГЕНЫ ГОМОЛОГИЧНЫХ ИММУНОДОМИНАНТНЫХ БЕЛКОВ МАССОЙ 28-КИЛОДАЛЬТОН Ehrlichia canis И ИХ ПРИМЕНЕНИЕ | |
| US20230106770A1 (en) | Reagents and methods for preventing, treating or limiting severe acute respiratory syndrome (SARS) coronavirus infection | |
| JP6373601B2 (ja) | アカバネウイルスに対して中和活性を有する抗体を誘導するペプチド | |
| CN117279648A (zh) | 疫苗组合物及其使用方法 |